Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 25, No 5 (February 10), 2007: pp. 603-604
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.08.9961

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, B. S.
Right arrow Articles by Robins, H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, B. S.
Right arrow Articles by Robins, H. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

Primary Disease Resection in Metastatic Breast Cancer Improves Survival

Brian S. Choi, H. Ian Robins

University of Wisconsin Comprehensive Cancer Center, Madison, WI

To the Editor:

We read with interest the article by Rapiti et al1 entitled, "Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at Diagnosis." In this retrospective observational study, the authors report a 50% reduction in breast cancer mortality in women who underwent surgical removal of the primary breast tumor. The survival advantage appeared to be significant only in women who had negative surgical margins. Furthermore, the effect of surgery on mortality was the greatest in the subgroup of patients with bone-only metastasis.

From these results the authors concluded that "removal of the primary tumor could be viewed as part of a multimodal strategy to prevent additional metastasization of cancer cells." The implication is that eradicating the primary tumor confers a survival advantage by way of preventing the occurrence of further metastatic disease. However, our review of the results suggests that the survival benefit is not from prevention of new metastasis. We noted the survival curves presented in Figure 1 begin to separate immediately, favoring the group that had surgery with negative margins. Given the doubling time of breast cancer cells, it would take several years for a small number of metastatic cells to grow into a clinically apparent tumor. We therefore conclude that the difference in survival must be attributable to another mechanism that takes effect immediately after surgery. Alternative hypotheses might include endocrine or cytokine-mediated effects that ultimately modify the behavior of the tumor cells in the metastatic sites.

It is possible that at least some of the difference in survival is due to confounding factors. For one thing, the authors did report that 28 patients died within 30 days of diagnosis—these patients presumably would have been too sick to have surgery or died before they had the chance. When these patients are excluded, the survival benefit for the surgery group is no longer statistically significant. Although the authors did adjust for many potential confounders, there may be other significant variables, such as comorbidities.

Despite the inherent limitations of this study, the apparent improvement in survival for the patients with bone-only metastasis is undoubtedly impressive, and worthy of further investigation.

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The authors indicated no potential conflicts of interest.

REFERENCES

1. Rapiti E, Verkooijen HM, Vlastos G, et al: Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24:2743-2749, 2006[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, B. S.
Right arrow Articles by Robins, H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, B. S.
Right arrow Articles by Robins, H. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online